Appili Therapeutics Inc.

APLIF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$989-$1,250$228-$524
Dep. & Amort.$3$4$3$4
Deferred Tax$0$0$0$0
Stock-Based Comp.$12$18$11$13
Change in WC$327$1,067-$201-$833
Other Non-Cash-$112$154$993$898
Operating Cash Flow-$759-$6$1,034-$442
Investing Activities
PP&E Inv.$0$0$0-$1
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0-$1
Financing Activities
Debt Repay.-$30-$29-$45-$28
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$47-$13-$16-$13
Financing Cash Flow-$77-$42-$61-$41
Forex Effect$60-$55$69$5
Net Chg. in Cash-$776-$103$1,042-$479
Supplemental Information
Beg. Cash$1,125$1,228$186$665
End Cash$349$1,125$1,228$186
Free Cash Flow-$759-$6$1,034-$443
Appili Therapeutics Inc. (APLIF) Financial Statements & Key Stats | AlphaPilot